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Introduction
The beta-1 adrenergic receptor (ADRB1) which is a G-protein coupled postsynaptic receptor mediates the physiological effects of catecholamines (1) . ADRB1 is encoded by a gene composed of 45 aminoacids and located on chromosome 10q24-26 where also positive linkage to affective disorders is reported (2,3) Many polymorphisms of ADRB1 gene were studied before, but 13 of them were found to change aminoacids in the ADRB1 protein (4,5). Ser49Gly and Gly389Arg have been identified as two functional polymorphisms among those variants. The change of adenine to guanine at 145th position results in the change of amino acid serine to glycine (Ser49Gly) and the substitution of cytosineguanine results in the change of amino acid glycine to arginine (Gly389Arg) (6, 7) . Although the majority of the studies for Ser49Gly and Gly389Arg were about cardiovascular disorders, the C allele of the Gly389Arg polymorphism was found to be a functional polymorphism associated with an enhanced coupling to the stimulatory Gs-protein and increased adenylcyclase activation which are often observed in affective disorder (8) . Another study about Gly389Arg polymorphism revealed an association of CC homozygosis with antidepressant treatment (9) .
It is known that low trait levels of extraversion are linked to increased vulnerability to major depression and anxiety (10) and a research about Ser49Gly functional polymorphism in the beta-1 adrenergic receptor has indicated an association between low extraversion and depression (11) . Also another study revealed that mental stress-induced myocardial ischemia were more common among the patients homozygous for the Ser49 allele (12) .
The relation of increased adenylcyclase activation, antidepressant treatment response, low extraversion properties and mental stress related cardiovascular disorders reveals the importance of those polymorphisms. But although there is remarkable evidence about the association of Ser49Gly and Gly389Arg polymorphisms in depression, only a limited number of studies have focused on those. We therefore tested a possible association of Ser49Gly and Gly389Arg polymorphism in the beta-1 adrenergic receptor in a sample of 144 patients diagnosed as major depression by comparing with 105 healthy controls.
Method Subjects
A total of 144 patients with major depression diagnosed according to DSM-IV criteria and 105 healthy controls between the ages of 18-75 were included in the study. The study included patients who were admitted to the outpatient clinic of the psychiatry department of a university hospital between August 2008 to October 2010. The standardized structured interviews were performed by the psychiatrists using SCID I and II questionnaires (13, 14, 15) . Patients with any current comorbid psychiatric disorder, personality disorder, alcohol or substance dependence, any other drug use, serious head injury story and patients who have any psychiatric disorder history in their first-degree relatives were excluded from the study. Among 167 first episode depression subjects, fifteen patients were excluded when recruiting patients because they met the criteria for the family history of a psychiatric disorder, and eight patients were excluded because of a comorbid psychiatric disorder. The subjects did not receive any pharmacological or nonpharmacological treatment during the sampling. All patients were chosen from the patients who had their first episode. A sample of 105 healthy subjects for the control group was non-related with the patients matched for age and gender. Both groups were from the same region of Turkey.
All patients and controls gave written informed consent. This study was approved by ethic committee.
Genotype Analysis
Deoxyribonucleic acid was extracted from frozen whole blood according to standard methods. Subjects were genotyped for two ADRB1 polymorphisms that result in serine/glycine (Ser49Gly) and arginine/glycine (Arg389Gly) amino acid substitutions (8, 16) .
Polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) with primers described by were used for both genotyping (16) . The following selected primary sequences for the analysis of Ser49Gly polymorphism in ADRB1 gene were applied. Forward Primer: 5' -CCG GGC TTC TGG GGT GTT CC -3'; Reverse Primer: 5' -GGCGAGGTGATGGCGAGGTAGC -3'.
Selected primary sequences for Gly389Arg polymorphism in ADRβ1 gene were as follows: Forward Primer: 5' CGCTCTGCTGGCTGCCCTTCTTCC 3'; Reverse Primer: 5' TGGGCTTCGAGTTCACCTGCTATC 3'.
Ser49Gly polymorphism of ADRB1 gene: 564 bp gene region including Ser49Gly polymorphism was amplified by PCR. 25 μl reaction mix prepared for each sample which was containing sterile distilled water (9.8 μl), the forward primer (0.5 μl), reverse primer (0.5 μl ), MgCl2 (1.5 μl), deoxinucleotidetriphosphate (dNTP) mixture (2.5 μl), genomic DNA (4.0 ml), Dimethyle Sulfoxide (DMSO) (2.5 μl), Taq DNA (0.2 μl) and buffer (2.5 μl).
Thirty-five PCR cycles were done for reaction. The conditions were denaturation for 4 min at 95°C, amplification (denaturation for 30s at 95°C, annealing for 30s at 64°C, extension for 45s at 72°C) and a final extension at 72°C for 7 min. Analysis of Ser49Gly polymorphism was performed by EcoO109I (DraI) restriction enzyme which was obtained from Escherichia coli. Amplified 564bp target region of ADRB1 gene did not include any cutting part for EcoO109I restriction enzyme; but the substitution of adenineguanine caused a cutting part. PCR products were visualized by electrophoresis on 2% agarose gels.
Gly389Arg polymorphism of ADR β1 gene: 530 bp gene region including Gly389Arg polymorphism was amplified by PCR. 25 μl reaction mix prepared for each sample which was containing sterile distilled water (9.8 μl), the forward primer (0.5 μl), reverse primer (0.5 μl ), MgCl2 (1.5 μl), deoxinucleotidetriphosphate (dNTP) mixture (2.5 μl), genomic DNA (4.0 ml), Dimethyle Sulfoxide (DMSO) (2.5 μl), Taq DNA (0.2 μl) and buffer (2.5 μl). The PCR conditions were denaturation for 4 min at 95°C, amplification (denaturation for 30s at 95°C, annealing for 30s at 64°C, extension for 45s at 72°C) and a final extension at 72°C for 7 min. Analysis of Gly389Arg polymorphism was performed by BcgI restriction enzyme which was obtained from Bacillus coagulans where the substitution of cytosine-guanine caused a cutting part on DNA. PCR products were visualized by electrophoresis on 2% agarose gels.
General statistical analyses were performed with SPSS software (version 15.0). Polymorphisms of ADRB1 gene between patients and controls were evaluated by using x 2 -test, ANOVA, t-test and correlation analysis. A p-value of less than 0.05 was considered statistically significant.
Results
A total of 144 major depressive disorder patients and 105 healthy controls were included in the study. Of 144 major depressive disorder patients, 112 (77.8%) were female, 32 (22.2%) were male. The mean age for major depressive disorder group was 43.08±13.59 years. Of 105 participants in the control group, 77 (73.3%) was female and 28 (26.7%) was male and the mean age for control group was 41.43±15.50 years. There wasn't any difference between controls and patients for gender and age (p=0.529; p=0.721).
Results of ADRB1 Ser49Gly Polymorphism
The results for ADRB1 Ser49Gly polymorphism in major depressive disorder and the control group were evaluated due to the size and number of fragments obtained by RFLP. The substitution of adenine to guanine at the extracellular aminoterminal 145, leads a change of serine aminoacid to glycine aminoacid in the 49 codon. According to our results we observed that the homozygous wild type (AA) genotype had a single 564 bp DNA fragment, homozygous mutant type (GG) had two DNA fragments with 345 bp and 219 bp sizes and the heterozygous type (AG) had three fragments with 564 bp , 345 bp. and 219 bp sizes (Figure 1 ).
Of the 144 participants in major depressive disorder group, 77 (53.5%) had homozygous wild type (AA), 57 (39.6%) had heterozygous type (AG) and 10 (6.9%) had mutant (GG) genotype. Of the 105 participants in the control group, 74 (70.5%) had homozygous wild type (AA), 23 (21.9%) had heterozygous type (AG) and 8 (7.6%) had mutant (GG) genotype. As shown in Table 1 , there wasn't any significant difference between the major depressive disorder and control groups after the analysis of genotype and allele frequencies of Ser49Gly ADRB (p=0.626; p=0.863).
Results of ADRB1Gly389Arg Polymorphism
The results for ADRB1 Gly389Arg polymorphism in major depressive disorder and control group were evaluated due to the size and number of fragments obtained by RFLP. The change of nucleotide cytosine(C) to guanine (G) at 1165 position resulted in the substitution of amino acid glycine to arginine. This polymorphic variant is located in the intracellular cytoplasmic tail portion (16) .
In major depressive disorder group, the homozygous wild type (GG) had a single 530bp DNA fragment, the homozygous mutant type (CC) had two DNA fragments with the sizes of 342bp and 154bp (homozygous mutant type also had another fragment which could not be seen in the gel) and finally heterozygous type (GC) had three DNA fragments with the sizes of 530bp, 342 bp and 154bp (Figure 2) .
Of the 144 participants in major depressive disorder group, 75 (52.1%) had homozygous wild type (GG) and 59 (41.0%) had heterozygous (GC) type and 10 (6.9%) had mutant homozygous (CC) genotype. Of the 105 participants in the control group, 56 (53.3%) had homozygous wild type (GG), 42 (40.0%) had heterozygous type (GC) and 7 (6.7%) had homozygous mutant (CC) genotype. As shown in Table 2 , there wasn't any significant difference between the major depressive disorder and control groups after the analysis of genotype and allele frequencies of Gly389Arg ADRB1 (p=0.625; p=0.914).
Discussion
Although some studies have investigated the functions of beta adrenergic receptors in affective disorders, there is little evidence about the polymorphisms of beta adrenergic receptors in major depressive disorder. It's necessary to compare the difference of polymorphisms between patients and controls to investigate the the susceptibility to major depressive disorder.
There are two known functional polymorphisms of ADRB1 gene, as Ser49Gly and Gly389Arg located on 10th chromosome (10q24-10q26) (3, 9) . Zill and his collegues have suggested that there weren't any relationship between the polymorphism of Gly389Arg and major depressive disorder (9) . However, this research also showed that beta-1-adrenergic receptor gene influence the antidepressant treatment response in major depression. Stein and his collegues have shown the polymorphisms of Ser49Gly and Gly389Arg would be associated with the introvert personalities, social phobia and depressive disorders (10) . Also another study have reported that the dysfunctional beta 1 adrenergic signaling have been found in subjects who were carriers of Ser49 and 389Gly while normal function was maintained for subjects who were homozygous for 49Gly/49Gly and 389Arg/389Arg (17) .
With this regard we investigated the polymorphisms and allele frequencies of Ser49Gly and Gly389Arg in a sample of Kokut 
Statistical Analysis
Turkish population for major depressive disorder. The mutant variants which may cause a conformational and functional change in ADRB1 receptors were compared between major depressive disorder patients and healthy controls. The mutant genotype (GG) for Ser49Gly polymorphism was found 6.9% for major depressive group and 7.6% for controls. Also the mutant genotype (GG) for Gly389Arg polymorphism was 6.9% and 6.7% in major depressive group and controls, respectively. Although we couldn't find any significant difference between the controls and major depressive disorder group for Ser49Gly and Gly389Arg polymorphisms, phenotypic complexity in psychiatric disorders should be considered. Conflicting results in the literature and in our research supports the hypothesis that specifik phenotypes can be effective in different depression groups. The heterogeneity of symptoms in MDD should be an important factor for determining polymorphisms. In a recent study conducted by Veen et al., had pointed out many gene sets associated with anhedonic depression that we should not generalize our results for all types of depression as no association for Ser49Gly and Gly389Arg polymorphisms (18) . Also all participants in this study were ethnically homogenous which is an important consideration for generalizing the results. The patients with family history of any psychiatric disorder were not enrolled in our study in order to exclude other genetic susceptibilities, and not to define the diagnoses according to the statements of the patients. But this would be another important reason to have negative results. Further longitudinal studies including first-degree relatives with depression would provide more information about Ser49Gly and Gly389Arg polymorphisms.
The limitations of our study was we did not sample all known variations of ADRB1 receptor genes that would have a small affect size or interactions with other genes. The small number of study subjects, the sample size of control subjects, the population stratification might affect the study and cause a negative result. We did not apply another scale for depression which was another limitation of the study. Although we included the patients in the first episode and medication naive patients to exclude the role of psychotropics and other long term environmental factors, some patients with first episode of major depression could include bipolar disorders.
Finally, our preliminary findings do not suggest that the polymorphism of Ser49Gly and Gly389Arg in ADRB1 gene has a major effect on major depressive disorder. Further case control studies by controlling types of major depressive disorders and including interactions of gene-gene, gene-environment and other variations with larger sample sizes are required to elucidate the role of B1 adrenergic gene polymorphisms in major depressive disorder. 
